3 pointers to help make biotech investing for beginners a little less intimidating.
A year-long exercise intent on proving that value and contrarian investing can be incredibly successful.
Historically, buy-and-hold investors will outperform over the long run, but it's not always as simple as it looks if you invest in these two types of companies.
These five stocks posted double-digit declines this past week.
First-quarter results for the prostate cancer drug maker were even uglier than anticipated.
There were a lot of things happening in the market this past week.
These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.
Analysts shift stance on Raytheon, Workday, and Dendreon.
After a crummy quarter, Dendreon looks to ramp up sales
Increasing competition and a lack of love from the insurance industry sinks Dendreon's chances of a decent quarter.